Biologic treatments for psoriasis - 21/08/11
Doi : 10.1016/j.jaad.2004.12.032
Cindy D. Kipnis, MD, Wendy A. Myers, MD, Mobolaji Opeola, MD, Alice B. Gottlieb, MD, PhD ⁎ 
From the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School
Reprint requests: Alice B. Gottlieb, MD, PhD, Clinical Research Center, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, 51 French St, New Brunswick, NJ 08901-0019.New Brunswick, New Jersey
Esquema
| This report reflects the best data available at the time the report was prepared, but caution should be exercised in interpreting the data; the results of future studies may require alteration of the conclusions or recommendations set forth in this report. Funding sources: None. Disclosure: Dr Gottlieb is a consultant, investigator, and speaker for Amgen, Biogen, Centocor, and Abbott; a consultant and investigator for Genentech; and a consultant and speaker for Wyeth. |
© 2005
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 52 - N° 4
P. 671-682 - avril 2005 Regresar al número
Artículo precedente
- What is the optimal dosing of imiquimod?
- Panniculitis
- Warren R. Heymann
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?